Navigation Links
Enrollment completed in 2 pivotal phase III studies of the investigational cancer drug vandetanib
Date:3/12/2008

li> ZEPHYR (vandetanib + best supportive care (BSC) versus BSC).

The ZEPHYR study is currently recruiting patients.

The Phase III program in NSCLC follows results from two Phase II trials where vandetanib was studied either alone or in combination with standard chemotherapy (docetaxel). Vandetanib is also being evaluated as a treatment option in medullary thyroid cancer and has been awarded Food and Drug Administration (FDA) orphan drug status and fast track designation for this tumor type.


'/>"/>

Contact: Asa Josefsson
asa.josefsson@astrazeneca.com
302-885-4109
Edelman Public Relations
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy
2. New 2008 Health Plan Directory Features Year-End 2007 Enrollment Data and 4,600 Key Executives
3. Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21
4. Medicares Drug Program Enrollment Up, Costs Down
5. MedicareCRM(TM) Simplifies Annual Enrollment Period for Medicare Health Plans and Beneficiaries
6. Boosts in Managed Care Enrollment Seen Across The Board
7. Devax Announces Completion of Enrollment of DIVERGE Trial of Novel Drug- Eluting Stent System for Bifurcation Lesions
8. Blue Cross Stop Smoking Phone Coaching Enrollments Jumped in October
9. Enrollment Growth Slows at U.S. Nursing Colleges and Universities in 2007 Despite Calls for More Registered Nurses
10. Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
11. Medicare Rx Beneficiaries Urged to Review Changes to Their Drug Plans and Compare with Other Plans During Open Enrollment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...he UK say that wound healing in depressed people i...ese and related reports find a place in the latest...sychological factors could have direct and indirec... according to the researchers. Depression and othe...
...eefe of Duke University Medical School in Durham, ...er in April issue of the Journal of pain. Patients... chronic pain of rheumatoid arthritis can reduce t...being, the researchers say. Dr. Francis says, "One...
...that exercising reduces the risk of heart disease.... for obese and fat people. But recent study shows ...art diseases because fitness and fatness are both ...ous heart ailments. Dr. Peter T. Katzmarzyk of Yor...
...just a year old, which was developed to fight resi...acteria are showing signs of resistance. The drug .... faecium) infections that are resistant to the ol...e has been that the new drug would help tackle the...
Other Medicine News:
(Date:9/5/2008)...ed From a Simple Blood Draw Have,the Potential to ...Range of Indications,...s is Currently Developing a Blood-Ba...and JERSEY CITY, New Jersey, September 5,/PRNewswi...SG), a leader in,the development of microRNA-based...
(Date:9/4/2008)...e PCR testing for the diagnostic .../- The U.S. Food & Drug,Administratio...HBV Test,the first assay for quantitating Hepatit...Roche,s real-time PCR technology to quantify the a...d. Doctors may use viral load,testing results to e...
(Date:9/4/2008)...t More Than 100 Sites in the U.S., ANN ARBOR, Mic..., a,privately-held biopharmaceutical company focus...ds to treat endocrine, metabolic and,cardiovascula... a second,Phase 3 clinical trial of Ophena(TM) (os...l therapy in development for the treatment of vagi...
(Date:9/4/2008)...ion for Targeted Therapies That Ensur... BEACH, Calif., and AMSTERDAM, Netherlands, Sept. ...ular cancer diagnostics,today announced the launc...lows physicians to quantitatively determine the ge..., progesterone receptor (PR) and Human Epidermal,g...
Breaking Medicine Technology:Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2No Link Between Amateur Boxing Long Term Brain Damage 3011 1No Link Between Amateur Boxing Long Term Brain Damage 3011 2Barr Will Host Calendar 2007 Third Quarter Earnings Conference Call on November 8 2007 3008 1Barr Will Host Calendar 2007 Third Quarter Earnings Conference Call on November 8 2007 3008 2Barr Will Host Calendar 2007 Third Quarter Earnings Conference Call on November 8 2007 3008 3October is Liver Awareness Month 3A The American Liver Foundation Urges All Americans to Pay Attention to Their Liver Every Day of the Year 3005 1October is Liver Awareness Month 3A The American Liver Foundation Urges All Americans to Pay Attention to Their Liver Every Day of the Year 3005 2October is Liver Awareness Month 3A The American Liver Foundation Urges All Americans to Pay Attention to Their Liver Every Day of the Year 3005 3New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti Cancer Potential Of Peregrines Anti PS Technology Platform 1096 1New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti Cancer Potential Of Peregrines Anti PS Technology Platform 1096 2New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti Cancer Potential Of Peregrines Anti PS Technology Platform 1096 3New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti Cancer Potential Of Peregrines Anti PS Technology Platform 1096 4
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
Medicine Products: